For research use only
Verdaine

Hormonal Health Research · 11 min read · February 4, 2026

The Landscape of Hormonal Health Research

How the literature on GHRH, GLP-1, and related pathways has matured over the past five years.

DM

Dr. Mira Halden

Chief Scientific Officer

The shift from single targets to pathway maps

For decades, hormonal research focused on individual receptors in isolation. A GHRH study examined GHRH. A GLP-1 study examined GLP-1. The past five years of literature have moved toward pathway-level models — maps of how incretins, growth-hormone-releasing peptides, and hypothalamic signaling interact.

The practical consequence is that isolated single-molecule studies are increasingly read in context. Researchers now ask how a given intervention shifts the shape of a signaling network, not just a single biomarker.

Women in the literature

Historically, preclinical hormonal studies over-sampled male models. The correction is underway: NIH guidance since 2016 has required sex as a biological variable, and recent literature increasingly reports female-specific dose-response curves, hormonal-cycle effects, and peri- and post-menopausal subgroups.

This matters for how women-focused research cohorts read the existing body of work. Older landmark papers may not generalize; newer ones increasingly do.

Editor's note

This article surveys the published literature and does not constitute medical advice or a health claim. Verdaine supplies research peptides for laboratory investigation only.

Keep reading

Join the research community

More from the Journal.

Monthly dispatches — literature summaries, protocol guides, and early access to the Research Academy.